Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

v3.20.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2017 6,370,661        
Balance at Dec. 31, 2017   $ 41,033 $ (40,234) $ 799
Issuance of common shares and warrants, net of offering costs of $529 (in shares) 1,322,965        
Issuance of common shares and warrants, net of offering costs of $529   5,840 5,840
Issuance of common shares, net of offering costs of $1,674 (in shares) 4,100,000        
Issuance of common shares, net of offering costs of $1,674   14,726 $ 14,726
Exercise of common share purchase warrants (in shares) 146,294       128,594
Exercise of common share purchase warrants   731 $ 731
Exercise of common stock options (in shares) 16,954       16,954
Exercise of common stock options   43 $ 43
Share-based compensation expense   620 620
Net loss   (5,734) (5,734)
Unrealized gain on marketable securities        
Balance (in shares) at Dec. 31, 2018 11,956,874        
Balance at Dec. 31, 2018   62,993 (45,968) 17,025
Exercise of common stock options (in shares) 50,000        
Exercise of common stock options   75 75
Share-based compensation expense   1,164 1,164
Net loss   (10,649) (10,649)
Unrealized gain on marketable securities   2 2
Balance (in shares) at Dec. 31, 2019 12,006,874        
Balance at Dec. 31, 2019   $ 64,232 $ 2 $ (56,617) $ 7,617